Qamar M, Fatima A, Tauseef A, Yousufzai M, Liaqat I, Naqvi Q
Cureus. 2024; 16(4):e57943.
PMID: 38738048
PMC: 11084851.
DOI: 10.7759/cureus.57943.
Keskin M, Avul S, Beyaz A, Koca N
Heliyon. 2024; 10(5):e27291.
PMID: 38486771
PMC: 10937677.
DOI: 10.1016/j.heliyon.2024.e27291.
Jayasekera D, Hartmann P
World J Hepatol. 2023; 15(5):609-640.
PMID: 37305367
PMC: 10251277.
DOI: 10.4254/wjh.v15.i5.609.
Moustafa S, Kassela K, Bampali M, Dovrolis N, Kakkanas A, Beloukas A
Viruses. 2022; 14(11).
PMID: 36423130
PMC: 9692671.
DOI: 10.3390/v14112521.
Brandt S, von Schnurbein J, Denzer C, Kratzer W, Wabitsch M
Front Endocrinol (Lausanne). 2022; 13:881982.
PMID: 35677722
PMC: 9169562.
DOI: 10.3389/fendo.2022.881982.
Effect of Probiotics Therapy on Nonalcoholic Fatty Liver Disease.
Huang Y, Wang X, Zhang L, Zheng K, Xiong J, Li J
Comput Math Methods Med. 2022; 2022:7888076.
PMID: 35677177
PMC: 9170412.
DOI: 10.1155/2022/7888076.
Acetate-mediated-obestatin modulation attenuates adipose-hepatic dysmetabolism in high fat diet-induced obese rat model.
Olaniyi K, Atuma C, Sabinari I, Mahmud H, Saidi A, Fafure A
Endocrine. 2022; 76(3):558-569.
PMID: 35229234
DOI: 10.1007/s12020-022-03023-w.
Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches.
Martinou E, Pericleous M, Stefanova I, Kaur V, Angelidi A
Diagnostics (Basel). 2022; 12(2).
PMID: 35204498
PMC: 8871470.
DOI: 10.3390/diagnostics12020407.
Profiling inflammatory and oxidative stress biomarkers following taurine supplementation: a systematic review and dose-response meta-analysis of controlled trials.
Faghfouri A, Shoura S, Fathollahi P, Shadbad M, Papi S, Ostadrahimi A
Eur J Clin Nutr. 2021; 76(5):647-658.
PMID: 34584225
DOI: 10.1038/s41430-021-01010-4.
Protein Hydrolysates Reduce Abdominal Adiposity and Ameliorate Metabolic Associated Fatty Liver Disease (MAFLD) in Western Diet Fed-ApoE Mice.
Santos-Sanchez G, Cruz-Chamorro I, Alvarez-Rios A, Fernandez-Santos J, Vazquez-Roman M, Rodriguez-Ortiz B
Antioxidants (Basel). 2021; 10(8).
PMID: 34439470
PMC: 8388992.
DOI: 10.3390/antiox10081222.
Multidimensional Biomarker Analysis Including Mitochondrial Stress Indicators for Nonalcoholic Fatty Liver Disease.
Chang E, Chang J, Kong I, Baik S, Kim M, Park K
Gut Liver. 2021; 16(2):171-189.
PMID: 34420934
PMC: 8924798.
DOI: 10.5009/gnl210106.
Infections at the nexus of metabolic-associated fatty liver disease.
Boeckmans J, Rombaut M, Demuyser T, Declerck B, Pierard D, Rogiers V
Arch Toxicol. 2021; 95(7):2235-2253.
PMID: 34027561
PMC: 8141380.
DOI: 10.1007/s00204-021-03069-1.
Efficacy of Weight Reduction on Pediatric Nonalcoholic Fatty Liver Disease: Opportunities to Improve Treatment Outcomes Through Pharmacotherapy.
Friesen C, Hosey-Cojocari C, Chan S, Csanaky I, Wagner J, Sweeney B
Front Endocrinol (Lausanne). 2021; 12:663351.
PMID: 33927697
PMC: 8076784.
DOI: 10.3389/fendo.2021.663351.
Cytokines, paraoxonase-1, periostin and non-invasive liver fibrosis scores in patients with non-alcoholic fatty liver disease and persistently elevated aminotransferases: A pilot study.
Milaciu M, Ciumarnean L, Matei D, Vesa S, Sabin O, Bocsan I
Exp Ther Med. 2021; 21(5):533.
PMID: 33815606
PMC: 8014973.
DOI: 10.3892/etm.2021.9965.
An Overview of the Molecular Mechanisms Contributing to Musculoskeletal Disorders in Chronic Liver Disease: Osteoporosis, Sarcopenia, and Osteoporotic Sarcopenia.
Yang Y, Kim D
Int J Mol Sci. 2021; 22(5).
PMID: 33807573
PMC: 7961345.
DOI: 10.3390/ijms22052604.
Association of Adipose Tissue and Adipokines with Development of Obesity-Induced Liver Cancer.
Rajesh Y, Sarkar D
Int J Mol Sci. 2021; 22(4).
PMID: 33671547
PMC: 7926723.
DOI: 10.3390/ijms22042163.
Controversies and Opportunities in the Use of Inflammatory Markers for Diagnosis or Risk Prediction in Fatty Liver Disease.
Lambrecht J, Tacke F
Front Immunol. 2021; 11:634409.
PMID: 33633748
PMC: 7900147.
DOI: 10.3389/fimmu.2020.634409.
The role of oxidative stress in the development of obesity and obesity-related metabolic disorders.
colak E, Pap D
J Med Biochem. 2021; 40(1):1-9.
PMID: 33584134
PMC: 7857849.
DOI: 10.5937/jomb0-24652.
Dietary Intervention Accelerates NASH Resolution Depending on Inflammatory Status with Minor Additive Effects on Hepatic Injury by Vitamin E Supplementation.
Klaebel J, Rakipovski G, Andersen B, Lykkesfeldt J, Tveden-Nyborg P
Antioxidants (Basel). 2020; 9(9).
PMID: 32882802
PMC: 7555643.
DOI: 10.3390/antiox9090808.
Randomized Clinical Trial: Bergamot Citrus and Wild Cardoon Reduce Liver Steatosis and Body Weight in Non-diabetic Individuals Aged Over 50 Years.
Ferro Y, Montalcini T, Mazza E, Foti D, Angotti E, Gliozzi M
Front Endocrinol (Lausanne). 2020; 11:494.
PMID: 32849284
PMC: 7431622.
DOI: 10.3389/fendo.2020.00494.